HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Natural Products Association Could Face Scrutiny Amid Legal Battles

This article was originally published in The Rose Sheet

Executive Summary

NPA credits its improved health and expanded member services to CEO Daniel Fabricant, who returned to the organization in April 2014 after three years at FDA. However, the exec is not without critics in the industry, and NPA now is embroiled in lawsuits defending the integrity of its leadership and fighting to remove a subversive element from its board of directors for alleged illegal conduct.

You may also be interested in...



NPA, Ex-CFO Weickert Exchange Unsavory Allegations In Legal Crossfire

In lawsuits pending in DC District Court, former NPA CFO Brent Weickert claims he was wrongfully terminated after raising concerns with the trade group's board about CEO Daniel Fabricant's conduct, while NPA is suing to remove board members who allegedly conspired with Weickert to oust Fabricant and serve their own personal interests.

NPA, Ex-CFO Weickert Exchange Unsavory Allegations In Legal Crossfire

In lawsuits pending in DC District Court, former NPA CFO Brent Weickert claims he was wrongfully terminated after raising concerns with the trade group's board about CEO Daniel Fabricant's conduct, while NPA is suing to remove board members who allegedly conspired with Weickert to oust Fabricant and serve their own personal interests.

Trade Groups Dismiss Jarrow’s Criticism Of FDA’s Fabricant

Dietary supplement industry trade groups disavow statements by Jarrow Formulas’ president that cast as industry consensus his criticism of Daniel Fabricant’s work as FDA’s top supplement program official.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS020005

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel